Feb 26, 2026 07:01AM
Jan 7, 2026 01:03AM
Jan 6, 2026 07:02AM
Jan 6, 2026 07:01AM
Dec 22, 2025 07:01AM
Dec 22, 2025 07:00AM
Dec 19, 2025 09:06AM TD Cowen on Biotechnology: '10+ Potential "Thome Run" Catalysts To Watch In 2026'
Dec 18, 2025 03:57AM
Nov 6, 2025 04:26AM
Nov 5, 2025 07:01AM
Nov 3, 2025 08:34AM
Nov 3, 2025 07:01AM
Oct 21, 2025 06:47AM
Oct 20, 2025 07:30AM Viridian Therapeutics Announces Royalty Financing with DRI Healthcare for up to $300 Million
Sep 15, 2025 07:02AM
Sep 15, 2025 07:01AM
Aug 6, 2025 06:30AM
May 20, 2025 07:01AM
May 20, 2025 07:00AM
May 7, 2025 04:31PM
May 7, 2025 04:15PM Viridian Therapeutics Receives FDA Breakthrough Therapy Designation for Veligrotug for the Treatment of Thyroid Eye Disease (TED)
May 6, 2025 07:00AM
Aug 14, 2024 03:58PM
Jun 11, 2024 06:00AM
May 9, 2024 06:55AM
May 9, 2024 06:55AM
May 8, 2024 07:00AM
Jul 10, 2023 04:01PM Viridian Therapeutics (VRDN) Reports Positive Data from Ongoing Phase 1/2 Trial of VRDN-001
Jul 10, 2023 04:01PM
May 9, 2023 04:01PM
Mar 8, 2023 07:00AM
Nov 30, 2022 10:39AM
Nov 30, 2022 09:34AM
Nov 14, 2022 06:59AM
Nov 14, 2022 06:59AM Viridian Announces Positive Data from Ongoing Phase 1/2 Trial Evaluating VRDN-001 in Patients with Thyroid Eye Disease (TED)
Mar 10, 2022 04:05PM
Jan 31, 2022 07:01AM
Jan 31, 2022 07:00AM
Jan 4, 2022 07:05AM
Jan 4, 2022 07:00AM
Nov 15, 2021 07:01AM
Nov 15, 2021 07:00AM Viridian Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for VRDN-001, an IGF-1R Antibody for the Treatment of Thyroid Eye Disease (TED)
Nov 4, 2021 04:05PM
Oct 14, 2021 08:03AM
Oct 14, 2021 08:00AM
Aug 11, 2021 07:00AM
Mar 25, 2021 04:05PM
Jan 20, 2021 08:06AM
Jan 19, 2021 07:00AM miRagen Therapeutics Announces Company Name Change to Viridian Therapeutics and New Executive Appointments, Including Expansion of Leadership Team

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All